Atria Investments Inc lessened its stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 8.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 22,632 shares of the business services provider’s stock after selling 2,200 shares during the period. Atria Investments Inc’s holdings in Exponent were worth $2,017,000 as of its most recent filing with the SEC.
Several other hedge funds have also bought and sold shares of EXPO. JPMorgan Chase & Co. grew its holdings in Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. Geode Capital Management LLC grew its holdings in Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares during the period. Barclays PLC grew its holdings in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares during the period. TimesSquare Capital Management LLC grew its holdings in Exponent by 22.4% during the fourth quarter. TimesSquare Capital Management LLC now owns 342,850 shares of the business services provider’s stock valued at $30,548,000 after purchasing an additional 62,760 shares during the period. Finally, DF Dent & Co. Inc. boosted its stake in shares of Exponent by 26.8% in the third quarter. DF Dent & Co. Inc. now owns 225,394 shares of the business services provider’s stock worth $25,983,000 after acquiring an additional 47,573 shares during the period. Institutional investors own 92.37% of the company’s stock.
Insider Transactions at Exponent
In related news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares of the company’s stock, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.10% of the company’s stock.
Exponent Stock Up 3.2 %
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period last year, the business earned $0.41 earnings per share. Research analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Friday, March 7th will be paid a $0.30 dividend. This is a positive change from Exponent’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, March 7th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.40%. Exponent’s dividend payout ratio is 56.60%.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What is a Death Cross in Stocks?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Are Penny Stocks a Good Fit for Your Portfolio?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Which Wall Street Analysts are the Most Accurate?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.